Clinical evidence for hydroxychloroquine and azithromycin combination therapy for COVID-19
![Thumbnail](/themes/edepositireland/images/white_rectangle.jpeg)
File Type:
PDFItem Type:
reportDate:
2020-04-02Author:
National Centre for Pharmacoeconomics (NCPE Ireland)Medicines Management Programme (MMP)National Medicines Information Centre (NMIC)COVID-19 Evidence Review Group for MedicinesAccess:
openAccessCitation:
National Centre for Pharmacoeconomics (NCPE Ireland), Medicines Management Programme (MMP), National Medicines Information Centre (NMIC), COVID-19 Evidence Review Group for Medicines, 'Clinical evidence for hydroxychloroquine and azithromycin combination therapy for COVID-19', [report], 2020-04-02Download Item:
Author: National Centre for Pharmacoeconomics (NCPE Ireland); Medicines Management Programme (MMP); National Medicines Information Centre (NMIC); COVID-19 Evidence Review Group for Medicines
Corporate name:
National Centre for Pharmacoeconomics (NCPE Ireland)Medicines Management Programme (MMP)
National Medicines Information Centre (NMIC)
COVID-19 Evidence Review Group for Medicines
Type of material:
reportCollections
Availability:
Full text availableKeywords:
Covid-19, Coronavirus, Hydroxychloroquine, Azithromycin, Combination therapyMetadata
Show full item recordLicences: